Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Buchsbaum

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Advances in Cancer Research|February 1, 2022
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stoneAlexander B Coley, Antonio Ward, Adam B Keeton, et al.
The Journal of Surgical Research|October 24, 2007
EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patientsChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Bioconjugate Chemistry|November 18, 2004
Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structureAhmad Safavy, Gunda I Georg, David Vander Velde, et al.
Annals of Surgical Oncology|April 25, 2007
Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib responseChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Analytical Biochemistry|January 30, 2002
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitroC Ryan Miller, Allen N Gustin, Donald J Buchsbaum, et al.
Cancer Immunology, Immunotherapy : CII|October 19, 2018
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growthTyler R McCaw, Mei Li, Dmytro Starenki, et al.
Surgery|March 27, 2007
Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancerChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
The Journal of Biological Chemistry|November 5, 2020
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cellsColleen M Britain, Nikita Bhalerao, Austin D Silva, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cellsJames A Bonner, Donald J Buchsbaum, Buck E Rogers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2015
Niclosamide Analogs for Treatment of Ovarian CancerChristen L Walters Haygood, Rebecca C Arend, Abhishek Gangrade, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Advances in Cancer Research|February 1, 2022
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stoneAlexander B Coley, Antonio Ward, Adam B Keeton, et al.
The Journal of Surgical Research|October 24, 2007
EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patientsChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Bioconjugate Chemistry|November 18, 2004
Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structureAhmad Safavy, Gunda I Georg, David Vander Velde, et al.
Annals of Surgical Oncology|April 25, 2007
Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib responseChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Analytical Biochemistry|January 30, 2002
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitroC Ryan Miller, Allen N Gustin, Donald J Buchsbaum, et al.
Cancer Immunology, Immunotherapy : CII|October 19, 2018
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growthTyler R McCaw, Mei Li, Dmytro Starenki, et al.
Surgery|March 27, 2007
Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancerChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
The Journal of Biological Chemistry|November 5, 2020
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cellsColleen M Britain, Nikita Bhalerao, Austin D Silva, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cellsJames A Bonner, Donald J Buchsbaum, Buck E Rogers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2015
Niclosamide Analogs for Treatment of Ovarian CancerChristen L Walters Haygood, Rebecca C Arend, Abhishek Gangrade, et al.
Pageof 16